1. Mei, Yan, Wang, Xiumei, Zhang, Ji, Chen, Jun, Jia, Guangshuai. 2023. Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response. In Nature cancer, 4, 1273-1291. doi:10.1038/s43018-023-00598-9. https://pubmed.ncbi.nlm.nih.gov/37460871/
2. Wang, Xu, Liu, Mingyue, Zhang, Jifeng, Zheng, Pan, Liu, Yang. . CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder. In Cell metabolism, 34, 1088-1103.e6. doi:10.1016/j.cmet.2022.07.005. https://pubmed.ncbi.nlm.nih.gov/35921817/
3. Flores, Rhonda, Zhang, Peng, Wu, Wei, Zheng, Pan, Liu, Yang. 2018. Siglec genes confer resistance to systemic lupus erythematosus in humans and mice. In Cellular & molecular immunology, 16, 154-164. doi:10.1038/cmi.2017.160. https://pubmed.ncbi.nlm.nih.gov/29503442/
4. Carter, Jason A, Matta, Bharati, Battaglia, Jenna, Atwal, Gurinder S, Barnes, Betsy J. 2023. Identification of pan-cancer/testis genes and validation of therapeutic targeting in triple-negative breast cancer: Lin28a-based and Siglece-based vaccination induces antitumor immunity and inhibits metastasis. In Journal for immunotherapy of cancer, 11, . doi:10.1136/jitc-2023-007935. https://pubmed.ncbi.nlm.nih.gov/38135347/
5. Chen, Zi, Bai, Fang-Fang, Han, Lu, Zhu, Zhou, Zhou, Lin-Fu. 2018. Targeting Neutrophils in Severe Asthma via Siglec-9. In International archives of allergy and immunology, 175, 5-15. doi:10.1159/000484873. https://pubmed.ncbi.nlm.nih.gov/29306942/
6. Lund, Sean J, Del Rosario, Pamela G B, Honda, Asami, Patras, Kathryn A, Prince, Lawrence S. . Sialic Acid-Siglec-E Interactions Regulate the Response of Neonatal Macrophages to Group B Streptococcus. In ImmunoHorizons, 8, 384-396. doi:10.4049/immunohorizons.2300076. https://pubmed.ncbi.nlm.nih.gov/38809232/
7. Carter, Jason A, Matta, Bharati, Battaglia, Jenna, Atwal, Gurinder S, Barnes, Betsy J. 2023. Identification of pan-cancer/testis genes and validation of therapeutic targeting in triple-negative breast cancer: Lin28a- and Siglece-based vaccination induces anti-tumor immunity and inhibits metastasis. In bioRxiv : the preprint server for biology, , . doi:10.1101/2023.05.09.539617. https://pubmed.ncbi.nlm.nih.gov/37214884/
8. Claude, Janine, Linnartz-Gerlach, Bettina, Kudin, Alexei P, Kunz, Wolfram S, Neumann, Harald. . Microglial CD33-related Siglec-E inhibits neurotoxicity by preventing the phagocytosis-associated oxidative burst. In The Journal of neuroscience : the official journal of the Society for Neuroscience, 33, 18270-6. doi:10.1523/JNEUROSCI.2211-13.2013. https://pubmed.ncbi.nlm.nih.gov/24227736/